Table 10.6c

Immunosuppression Use: Maintenance Between Discharge

and One Year Posttransplant, 1993 to 2002

Recipients with Intestine Transplants

		Year of Transplant
		1993	1994	1995	1996	1997	1998	1999	2000	2001	2002
Transplants		34	23	46	45	68	70	73	81	111	107
Tx With Follow-up Immunosuppression Info		6	14	28	28	35	41	42	56	79	80
Corticosteroids	Category Usage	100.0%	92.9%	92.9%	100.0%	94.3%	97.6%	100.0%	100.0%	86.1%	92.5%
	Steroids	100.0%	92.9%	92.9%	100.0%	94.3%	97.6%	100.0%	100.0%	86.1%	92.5%
Cyclosporine	Category Usage	33.3%	21.4%	14.3%	10.7%	5.7%	2.4%	2.4%	0.0%	0.0%	1.3%
	Cyclosporin	33.3%	21.4%	7.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	2.4%	0.0%	0.0%	1.3%
	Neoral	0.0%	0.0%	7.1%	10.7%	5.7%	2.4%	0.0%	0.0%	0.0%	0.0%
Tacrolimus	Category Usage	83.3%	85.7%	92.9%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%
	FK506	83.3%	85.7%	92.9%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%
Antimetabolites	Category Usage	33.3%	14.3%	42.9%	67.9%	34.3%	34.1%	35.7%	16.1%	13.9%	11.3%
	Azathioprine	33.3%	14.3%	28.6%	25.0%	17.1%	4.9%	16.7%	0.0%	11.4%	1.3%
	Mycophenolate mofetil	0.0%	0.0%	28.6%	57.1%	22.9%	29.3%	26.2%	16.1%	2.5%	10.0%
Other	Category Usage	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	23.8%	67.9%	24.1%	26.3%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	23.8%	67.9%	24.1%	26.3%

Source: OPTN/SRTR Data as of May 3, 2004.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.